
Aegon's stakes in a.s.r. and Standard Life, worth approximately €5.4 billion combined, support an attractive sum-of-the-parts valuation for Transamerica. H1 operating profit increased 9%, while operating capital generation rose 27%, reinforcing the outlook for the core US insurance business. Expanded share buybacks and an 11% increase in the interim dividend demonstrate management's commitment to returning capital to shareholders.










